To further elucidate whether targeting SDCBP enhances the anti-cancer activity of metformin in a TNBC model, murine 4T1 cells were infected with adenoviral SDCBP shRNA, resulting in the complete loss of SDCBP and BACH1 expression (Fig. EV1J). Here, SDCBP is linked to cancer.